James Mandell, Director at bluebird bio, Inc. (BLUE), sold 1,500 shares at $148.75 ($223K) on 2015-08-10, disclosed to the SEC on 2015-08-12.
Scheduled sale ($223k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $146.83 | 626 | $92K | 41.3% |
| 2 | $147.88 | 299 | $44K | 19.9% |
| 3 | $148.75 | 194 | $29K | 13.0% |
| 4 | $150.28 | 164 | $25K | 11.1% |
| 5 | $151.71 | 127 | $19K | 8.7% |
| 6 | $152.86 | 90 |
| $14K |
| 6.2% |
| Total | $148.44 avg | 1,500 | $223K | 100% |
| Filing → |
| BLUE | SELL | 2017-02-17 | $84K | — | Filing → |
| BLUE | SELL | 2017-02-16 | $952K | — | Filing → |
| BLUE | SELL | 2017-02-02 | $600K | — | Filing → |